The septin-binding protein anillin is overexpressed in diverse human tumors

Clinical Cancer Research

Volumn 11, Issue 19 I, 2005, Pages 6780-6786

  Hall, Peter A ^a   Todd, Christopher B ^a   Hyland, Paula L ^a   McDade, Simon S ^a   Grabsch, Heike ^b   Dattani, Mit ^b   Hillan, Kenneth J ^c   Russell, S E Hilary ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; ANILLIN; BIOLOGICAL MARKER; COMPLEMENTARY DNA; KI 67 ANTIGEN; MESSENGER RNA; SEPTIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST TUMOR; CARCINOGENESIS; COLORECTAL TUMOR; DNA MICROARRAY; ENDOMETRIUM TUMOR; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY TUMOR; LIVER TUMOR; LUNG TUMOR; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OVARY TUMOR; PANCREAS TUMOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

ACTINS; BLOTTING, NORTHERN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL NUCLEUS; CENTRAL NERVOUS SYSTEM; CLONING, MOLECULAR; CONTRACTILE PROTEINS; CYTOSKELETAL PROTEINS; DNA, COMPLEMENTARY; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MICROFILAMENT PROTEINS; MITOCHONDRIAL PROTEINS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE DISTRIBUTION; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 26444560603     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-0997     Document Type: Article

References (48)

1. Glotzer M. The molecular requirements for cytokinesis. Science 2005;307:1735-9.
2. Field CM, Alberts BM. Anillin, a contractile ring protein that cycles from the nucleus to the cell cortex. J Cell Biol 1995;131:165-78.
3. Oegema K, Savoian MS, Mitchison TJ, Field CM. Functional analysis of a human homologue of the Drosophila actin binding protein anillin suggests a role in cytokinesis. J Cell Biol 2000;150:539-52.
4. Miller KG, Fields CN, Alberts BM. Actin binding proteins from Drosophila embryos: a complex network of interacting proteins detected by F-actin chromatography. J Cell Biol 1989;109:2963-75.
5. Straight AF, Field CM, Mitchison TJ. Anillin binds non muscle myosin II and regulates the contractile ring. Mol Biol Cell 2005;16:193-201.
6. Kinoshita M, Field CM, Coughlin ML, Straight AF, Mitchison TJ. Self- and actin-templated assembly of mammalian septins. Dev Cell 2002;3:791-802.
7. Hall PA, Russell SE. The pathobiology of the septin gene family. J Pathol 2004;205:489-505.
8. Hall PA, Jung K, Hillan KJ, Russell SEH. Expression profiling the human septin gene family. J Pathol 2005; 206:267-8.
9. Sui L, Zhang W, Liu Q, et al. Cloning and functional characterization of human septin 10, a novel member of septin family cloned from dendritic cells. Biochem Biophys Res Commun 2003;304:393-8.
10. Scott RJ, Hall PA, Haldane JS, et al. A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol 1991;165:173-8.
11. Whitfield ML, Sherlock G, Saldanha AJ, et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell 2002;13:1977-2000.
12. Robertson C, Church SW, Nagar HA, Price J, Hall PA, Russell SE. Properties of SEPT9 isoforms and the requirement for GTP binding. J Pathol 2004;203: 519-27.
13. Scott M, Hyland PL, McGregor G, Hillan KJ, Russell SE, Hall PA. Multimodality expression profiling shows SEPT9 to be over-expressed in a wide range of human tumours. Oncogene 2005;24:4688-700.
14. Stromer MN. The cytoskeleton in skeletal cardiac and smooth muscle cells. Histol Histopathol 1998;13: 283-91.
15. Wright NA, Alison M. The biology of epithelial cell populations. Oxford, United Kingdom: Oxford University Press; 1984.
16. Rajasekhar VK, Holland EC. Postgenomic global analysis of translational control induced by oncogenic signaling. Oncogene 2004;23:3248-64.
17. Giansanti MG, Bonaccorsi S, Gatti M. The role of anillin in meiotic cytokinesis of Drosophila males. J Cell Sci 1999;112:2323-34.
18. Tulina N, Matunis E. Control of stem cell self-renewal in Drosophila spermatogenesis by JAK-STAT signaling. Science 2001;294:2546-9.
19. Giansanti MG, Farkas RM, Bonaccorsi S, et al. Genetic dissection of meiotic cytokinesis in Drosophila males. Mol Biol Cell 2004;15:2509-22.
20. Ma XJ, Salunga R, Tuggle JT, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A 2003;100:5974-9.
21. Moreno-Bueno G, Sanchez-Estevez C, Cassia R, et al. Differential gene expression profile in endometrioid and nonendometrioid endometrial cacrinoma: STK15 is frequently over-expressed and amplified in nonendometrioid carcinomas. Cancer Res 2003;63: 5697-702.
22. Chen X, Leung SY, Yuen ST, et al. Variation in gene expression patterns in human gastric cancers. Mol Biol Cell 2003;14:3208-15.
23. Landreville S, Lupien C, Salesse C. Identification of genes involved in uveal melanoma by suppressive subtraction hybridisation. Abstract L256, ASCB 44th Annual Meeting, Washington: 2004.
24. Vogt N, Lefevre SH, Apiou F, et al. Molecular structure of double-minute chromosomes bearing amplified copies of the epidermal growth factor receptor gene in gliomas. Proc Natl Acad Sci U S A 2004;101: 11368-73.
25. Arteaga CL. Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia. Semin Oncol 2002;29:3-9.
26. Koon N, Schneider-Stock R, Sarlomo-Rikala M, et al. Molecular targets for tumour progression in gastrointestinal stromal tumours. Gut 2004;53: 235-40.
27. Tomonaga T, Matsushita K, Yamaguchi S, et al. Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer. Cancer Res 2003; 63:3511-6.
28. Hayward DG, Clarke RB, Faragher AJ, Pillai MR, Hagan IM, Fry AM. The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer. Cancer Res 2004;64:7370-6.
29. de la Guardia C, Casiano CA, Trinidad-Pinedo J, Baez A. CENP-F gene amplification and overexpression in head and neck squamous cell carcinomas. Head Neck 2001;23:104-12.
30. Katayama H, Brinkley WR, Sen S. The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev 2003;22:451-64.
31. Blackhall FH, Wigle DA, Jurisica I, et al. Validating the prognostic value of marker genes derived from a non-small cell lung cancer microarray study. Lung Cancer 2004;46:197-204.
32. Ghobrial IM, McCormick DJ, Kaufmann SH, et al. Proteomic analysis of mantle-cell lymphoma by protein microarray. Blood 2005;105:3722-30.
33. Winkles JA, Alberts GF. Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues. Oncogene 2005;24: 260-6.
34. Duxbury MS, Ashley SW, Whang EE. Inhibition of pancreatic adenocarcinoma cellular invasiveness by blebbistatin: a novel myosin II inhibitor. Biochem Biophys Res Commun 2004;313:992-7.
35. Li ZH, Spektor A, Varlamova O, Bresnick AR. Mts1 regulates the assembly of nonmuscle myosin-IIA. Biochemistry 2003;42:14258-66.
36. Obungu VH, Lee Burns A, Agarwal SK, Chandrasekharapa SC, Adelstein RS, Marx SJ. Menin, a tumor suppressor, associates with non-muscle myosin II-A heavy chain. Oncogene 2003;22: 6347-58.
37. Atalay C, Atalay G, Yilmaz KB, Altinok M. The role of anti-CENP-B and anti-SS-B antibodies in breast cancer. Neoplasma 2005;52:32-5.
38. Pederson T, Aebi U. Actin in the nucleus: what form and what for? J Struct Biol 2003;140:3-9.
39. Blessing CA, Ugrinova GT, Goodson HV. Actin and ARPs: action in the nucleus. Trends Cell Biol 2004;14: 435-42.
40. Philimonenko VV, Zhao J, Iben S, et al. Nuclear actin and myosin I are required for RNA polymerase I transcription. Nat Cell Biol 2004;6:1165-72.
41. Zhang S, Kohler C, Hemmerich P, Grosse F. Nuclear DNA helicase II (RNA helicase A) binds to an F-actin containing shell that surrounds the nucleolus. Exp Cell Res 2004;293:248-58.
42. Oma Y, Nishimori K, Harata M. The brain specific actin related protein ArpNα interacts with the transcriptional co-repressor CtBP. Biochem Biophys Res Commun 2003;310:521-8.
43. Kuroda Y, Oma Y, Nishimori K, Ohta T, Harata M. Brian specific expression of the nuclear actin-related protein ArpNα and its involvement in mammalian SWI/SNF chromatin remodelling complex. Biochem Biophys Res Commun 2002;299:328-34.
44. Percipalle P, Fomproix N, Kylberg K, et al. An actin-ribonucleoprotein interaction is involved in transcription by RNA polymerase II. Proc Natl Acad Sci U S A 2003;100:6475-80.
45. Krauss SW, Chen C, Penman S, Heald R. Nuclear actin and protein 4.1: essential interactions during nuclear assembly in vitro. Proc Natl Acad Sci U S A 2003;100:10752-7.
46. Okorokov AL, Rubbi CP, Metcalfe S, Milner J. The interaction of p53 with the nuclear matrix is mediated by F-actin and modulated by DNA damage. Oncogene 2002;21:356-67.
47. Carmo-Fonseca M, Platini M, Swedlow JR. Macromolecular mobility inside the cell nucleus. Trends Cell Biol 2002;12:491-5.
48. Fomproix N, Percipalle P. An actin-myosin complex on actively transcribing genes. Exp Cell Res 2004; 294:140-8.